Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Rocci

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Clinical Pharmacokinetics|August 1, 1987
The pharmacokinetics and pharmacodynamics of newer inotropic agentsM L Rocci, H Wilson
Computer Programs in Biomedicine|June 1, 1983
LAGRAN program for area and moments in pharmacokinetic analysisM L Rocci, W J Jusko
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
Inhibition of carbamazepine metabolism by cimetidineD M Grasela, M L Rocci
Journal of Pharmaceutical Sciences|October 1, 1981
Blood collection technique: no effect on in vitro protein binding of prednisoloneM L Rocci, W J Jusko
Journal of Pharmaceutical Sciences|November 1, 1981
Dose-dependent protein binding and disposition of prednisolone in rabbitsM L Rocci, W J Jusko
Quality Assurance (San Diego, Calif.)|December 1, 1995
GMP criteria for retest and failure analysis. Handling out-of-specification results in the pharmaceutical quality control laboratoryA E Klein, M L Rocci
Clinical Pharmacokinetics|December 1, 1989
Effects of age on the elimination of labetalolM L Rocci, T Valiquett, M A Sirgo
Journal of Pharmaceutical Sciences|February 1, 1986
Inhibition of pentoxifylline clearance by cimetidineD R Luke, M L Rocci, C Hoholick
Pharmaceutical Research|November 27, 2013
Morphine inhibition of theophylline clearanceM L Rocci, P Mojaverian, C L Saccar
Clinical Pharmacology and Therapeutics|October 1, 1988
Trimethoprim alters the disposition of procainamide and N-acetylprocainamideT Kosoglou, M L Rocci, P H Vlasses
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Clinical Pharmacokinetics|August 1, 1987
The pharmacokinetics and pharmacodynamics of newer inotropic agentsM L Rocci, H Wilson
Computer Programs in Biomedicine|June 1, 1983
LAGRAN program for area and moments in pharmacokinetic analysisM L Rocci, W J Jusko
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
Inhibition of carbamazepine metabolism by cimetidineD M Grasela, M L Rocci
Journal of Pharmaceutical Sciences|October 1, 1981
Blood collection technique: no effect on in vitro protein binding of prednisoloneM L Rocci, W J Jusko
Journal of Pharmaceutical Sciences|November 1, 1981
Dose-dependent protein binding and disposition of prednisolone in rabbitsM L Rocci, W J Jusko
Quality Assurance (San Diego, Calif.)|December 1, 1995
GMP criteria for retest and failure analysis. Handling out-of-specification results in the pharmaceutical quality control laboratoryA E Klein, M L Rocci
Clinical Pharmacokinetics|December 1, 1989
Effects of age on the elimination of labetalolM L Rocci, T Valiquett, M A Sirgo
Journal of Pharmaceutical Sciences|February 1, 1986
Inhibition of pentoxifylline clearance by cimetidineD R Luke, M L Rocci, C Hoholick
Pharmaceutical Research|November 27, 2013
Morphine inhibition of theophylline clearanceM L Rocci, P Mojaverian, C L Saccar
Clinical Pharmacology and Therapeutics|October 1, 1988
Trimethoprim alters the disposition of procainamide and N-acetylprocainamideT Kosoglou, M L Rocci, P H Vlasses
Pageof 7